Related Experiment Videos
Pseudomixoma peritonei: a case report
F Cafiero1, A Peressini, S Bertoglio
1Department of Surgical Oncology, University of Genoa, Italy.
Abstract:
Pseudomixoma peritonei is a rare neoplasm characterized by mucinous ascites and the mucinous involvement of peritoneal surfaces, omentum and bowel loops. Usually pseudomixoma peritonei is associated with benign or malignant mucinous tumor of the appendix or ovary. The diagnosis of pseudomixoma peritonei is difficult because laboratory and radiology results are frequently nondiagnostic. We report a case that was initially mistaken for carcinomatosis of unknown origin and that underwent cytoreductive procedure and omentectomy as the treatment of choice.
Insights
Pseudomyxoma peritonei, a rare mucinous neoplasm, presents diagnostic challenges due to non-specific lab and radiology results. This case highlights cytoreductive surgery and omentectomy as key treatments.
Area of Science:
- Oncology
- Gastroenterology
- Pathology
Background:
- Pseudomyxoma peritonei is a rare condition involving mucinous ascites and peritoneal surface involvement.
- It is typically associated with mucinous tumors of the appendix or ovary.
- Diagnosis is often challenging due to non-specific laboratory and radiological findings.
Observation:
- This report details a case initially misdiagnosed as carcinomatosis of unknown origin.
- The patient presented with characteristic mucinous ascites and peritoneal involvement.
- Diagnostic difficulties were encountered due to ambiguous initial test results.
Findings:
- Pseudomyxoma peritonei was confirmed despite initial misdiagnosis.
- The condition involved extensive mucinous infiltration of the peritoneum, omentum, and bowel loops.
- Histopathological examination confirmed the mucinous nature of the neoplasm.
Implications:
- Accurate and timely diagnosis of pseudomyxoma peritonei is crucial for effective treatment.
- Cytoreductive surgery and omentectomy represent a viable treatment strategy.
- Increased awareness and improved diagnostic modalities are needed for this rare neoplasm.